Patient’s Perception of Symptoms Related to Morning Activity in Chronic Obstructive Pulmonary Disease: The SYMBOL Study
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: Patients with chronic obstructive pulmonary disease (COPD) experience more problematic respiratory symptoms and have more trouble performing daily activities in the morning. The aim of this study was to assess the perception of COPD symptoms related to morning activities in patients with severe airflow limitation. Methods: Data of 133 patients with severe airflow limitation were analyzed in a prospective, non-interventional study. A clinical symptom questionnaire was completed by patients at baseline. In patients having morning symptoms, defined by at least one or more prominent or aggravating symptom during morning activities, a morning activity questionnaire was also completed at baseline and following 2 months of COPD treatment. Results: The most frequently reported COPD symptom was breathlessness (90.8%). Morning symptoms were reported in 76 (57%) patients; these had more frequent and severe clinical COPD symptoms. The most frequently reported morning activity was getting out of bed (82.9%). The long acting muscarinic antagonist (odds ratio [OR], 6.971;95% confidence interval [CI], 1.317 to 11.905) and chest tightness (OR, 0.075; 95% CI, 0.011 to 0.518) were identified as significantly related to absence of morning symptoms. There was no significant correlation between the degree of forced expiratory volume in 1 second improvement and severity score differences of all items of morning activity after 2-month treatment. Conclusions: Fifty-seven percent of COPD patients with severe airflow limitation have morning symptoms that limit their morning activities. These patients also have more prevalent and severe COPD symptoms. The results of this study therefore provide valuable information for the development of patient-reported outcomes in COPD.
Abstract
Background/Aims: Patients with chronic obstructive pulmonary disease (COPD) experience more problematic respiratory symptoms and have more trouble performing daily activities in the morning. The aim of this study was to assess the perception of COPD symptoms related to morning activities in patients with severe airflow limitation. Methods: Data of 133 patients with severe airflow limitation were analyzed in a prospective, non-interventional study. A clinical symptom questionnaire was completed by patients at baseline. In patients having morning symptoms, defined by at least one or more prominent or aggravating symptom during morning activities, a morning activity questionnaire was also completed at baseline and following 2 months of COPD treatment. Results: The most frequently reported COPD symptom was breathlessness (90.8%). Morning symptoms were reported in 76 (57%) patients; these had more frequent and severe clinical COPD symptoms. The most frequently reported morning activity was getting out of bed (82.9%). The long acting muscarinic antagonist (odds ratio [OR], 6.971;95% confidence interval [CI], 1.317 to 11.905) and chest tightness (OR, 0.075; 95% CI, 0.011 to 0.518) were identified as significantly related to absence of morning symptoms. There was no significant correlation between the degree of forced expiratory volume in 1 second improvement and severity score differences of all items of morning activity after 2-month treatment. Conclusions: Fifty-seven percent of COPD patients with severe airflow limitation have morning symptoms that limit their morning activities. These patients also have more prevalent and severe COPD symptoms. The results of this study therefore provide valuable information for the development of patient-reported outcomes in COPD.
참고문헌 (37)
- ". 2011 rev" (2011)[URL]
- Kim YJ, "Biomass smoke induced bronchial anthracofibrosis: presenting features and clinical course", Respir Med, 103, pp.757~765 (2009)
- Viegi G, "Epidemiology of chronic obstructive pulmonary disease (COPD)", Respiration, 68, pp.4~19 (2001)
- Kim DS, "Prevalence of chronic obstructive pulmonary disease in Korea: a population-based spirometry survey", Am J Respir Crit Care Med, 172, pp.842~847 (2005)
- Hilleman DE, "Pharmacoeconomic evaluation of COPD", Chest, 118, pp.1278~1285 (2000)
- Miravitlles M, "Decisiones sobre Antibioticoterapia y Farmacoeconomía en la EPOC: pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD", Chest, 121, pp.1449~1455 (2002)
- Masa JF, "Costs of chronic obstructive pulmonary disease in Spain: estimation from a population-based study", Arch Bronconeumol, 40, pp.72~79 (2004)
- Rutschmann OT, "Knowledge of guidelines for the management of COPD: a survey of primary care physicians", Respir Med, 98, pp.932~937 (2004)
- Barr RG, "Physician and patient perceptions in COPD: the COPD Resource Network Needs Assessment Survey", Am J Med, 118, pp.1415~ (2005)
- Haughney J, "Exacerbations of COPD: quantifying the patient’s perspective using discrete choice modelling", Eur Respir J, 26, pp.623~629 (2005)
- Rennard S, "Impact of COPD in North America and Europe in 2000: subjects’ perspective of Confronting COPD International Survey", Eur Respir J, 20, pp.799~805 (2002)
- Miravitlles M, "Patient’s perception of exacerbations of COPD: the PERCEIVE study", Respir Med, 101, pp.453~460 (2007)
- Partridge MR, "Patient insight into the impact of chronic obstructive pulmonary disease in the morning: an internet survey", Curr Med Res Opin, 25, pp.2043~2048 (2009)
- Kessler R, "Symptom variability in patients with severe COPD: a pan-European cross-sectional study", Eur Respir J, 37, pp.264~272 (2011)
- Postma DS, "The effects of oral slow-release terbutaline on the circadian variation in spirometry and arterial blood gas levels in patients with chronic airflow obstruction", Chest, 87, pp.653~657 (1985)
- Calverley PM, "Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease", Thorax, 58, pp.855~860 (2003)
- van Noord JA, "Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD", Chest, 129, pp.509~517 (2006)
- McCarley C, "A pilot home study of temporal variations of symptoms in chronic obstructive lung disease", Biol Res Nurs, 9, pp.8~20 (2007)
- American Thoracic Society, "Standardization of spirometry, 1994 update", Am J Respir Crit Care Med, 152, pp.1107~1136 (1995)
- Morris JF, "Spirometry in the evaluation of pulmonary function", West J Med, 125, pp.110~118 (1976)
- Sensormedics, "Pulmonary Utilities Operator’s Manual: Predicted Normal Equations", Sensormedics Co., ~ (1988)
- Fritzsche A, "Effects of medical and psychological treatment of depression in patients with COPD: a review", Respir Med, 105, pp.1422~1433 (2011)
- Monteleone P, "The circadian basis of mood disorders: recent developments and treatment implications", Eur Neuropsychopharmacol, 18, pp.701~711 (2008)
- Mahler DA, "Changes in dyspnea, health status, and lung function in chronic airway disease", Am J Respir Crit Care Med, 151, pp.61~65 (1995)
- Partridge MR, "Effect on lung function and morning activities of budesonide", formoterol versus salmeterol, Ther Adv Respir Dis, pp.2009, 3[DOI]
- Welte T, "Efficacy and tolerability of budesonide", formoterol added to tiotropium in patients with chronic obstructive pulmonary disease, 2009, pp.180, 741~750
- Killian KJ, "Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow limitation", Am Rev Respir Dis, 146, pp.935~940 (1992)
- Ferrer M, "Chronic obstructive pulmonary disease stage and health-related quality of life. The Quality of Life of Chronic Obstructive Pulmonary Disease Study Group", Ann Intern Med, 127, pp.1072~1079 (1997)
- Curtis JR, "Pulmonary rehabilitation in chronic respiratory insufficiency 7: Health-related quality of life among patients with chronic obstructive pulmonary disease", Thorax, 49, pp.162~170 (1994)
- Oga T, "Longitudinal deteriorations in patient reported outcomes in patients with COPD", Respir Med, 101, pp.146~153 (2007)
- Cazzola M, "Outcomes for COPD pharmacological trials: from lung function to biomarkers", Eur Respir J, 31, pp.416~469 (2008)
- Barnes PJ, "Systemic manifestations and comorbidities of COPD", Eur Respir J, 33, pp.1165~1185 (2009)
- Cazzola M, "Prevalence of comorbidities in patients with chronic obstructive pulmonary disease", Respiration, 80, pp.112~119 (2010)
- van den Bemt L, "Monitoring of patients with COPD: a review of current guidelines’ recommendations", Respir Med, 102, pp.633~641 (2008)
- Benzo RP, "Physical activity, health status and risk of hospitalization in patients with severe chronic obstructive pulmonary disease", Respiration, 80, pp.10~18 (2010)
- Jones PW, "Development and first validation of the COPD assessment test", Eur Respir J, 34, pp.648~654 (2009)
- Partridge MR, "Development and validation of the capacity of daily living during the morning questionnaire and the global chest symptoms questionnaire in COPD", Eur Respir J, 36, pp.96~104 (2010)